Jan 20 (Reuters) - Novavax said on Tuesday it was entering into a licensing agreement with Pfizer to develop vaccine products for infectious diseases. I stopped shopping for a year and saved $6 ...
They aren't just "pandemic stocks." ...
Pfizer (NYSE:PFE) has started a Phase 1 trial of a new tafamidis tablet formulation aimed at improving manufacturing ...
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...
Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
Pfizer Inc (NYSE:PFE) develops medicines and vaccines across multiple therapeutic areas, contributing to the S&P 500 ...
Pfizer CEO Dr. Albert Bourla argued that President Donald Trump deserves a Nobel Peace Prize for Operation Warp Speed—the project behind the development of the COVID-19 vaccine in 2020. Bourla’s ...
The announcement Monday from Pfizer and its German partner BioNTech that their coronavirus vaccine appears to be 90% effective thrilled medical experts around the world and presented a glimmer of hope ...
Pfizer has reached a turning point.
Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting that they should have won President Trump a Nobel Peace Prize, in response to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results